| scholarly article | Q13442814 |
| retracted paper | Q45182324 |
| P2093 | author name string | Shigeaki Kato | |
| Akiko Murayama | |||
| Ken-ichi Takeyama | |||
| Junn Yanagisawa | |||
| Mi-sun Kim | |||
| P2860 | cites work | Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex | Q22009519 |
| A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins | Q24299387 | ||
| Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence | Q24300878 | ||
| Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex | Q24313231 | ||
| A subfamily of RNA-binding DEAD-box proteins acts as an estrogen receptor alpha coactivator through the N-terminal activation domain (AF-1) with an RNA coactivator, SRA | Q24545696 | ||
| The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen | Q27766417 | ||
| Sequence and characterization of a coactivator for the steroid hormone receptor superfamily | Q27860465 | ||
| A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors | Q27860552 | ||
| The nuclear receptor superfamily: the second decade | Q27860725 | ||
| The coregulator exchange in transcriptional functions of nuclear receptors | Q28131759 | ||
| Mutations in the glucocorticoid receptor zinc finger region that distinguish interdigitated DNA binding and transcriptional enhancement activities | Q46049211 | ||
| DNA sequences in the rat parathyroid hormone-related peptide gene responsible for 1,25-dihydroxyvitamin D3-mediated transcriptional repression. | Q52520893 | ||
| RETRACTED: Nuclear Receptor Function Requires a TFTC-Type Histone Acetyl Transferase Complex | Q55920649 | ||
| Parathyroid hormone modulation of 25-hydroxyvitamin D3 metabolism by cultured chick kidney cells is mimicked and enhanced by forskolin | Q70077729 | ||
| No enzyme activity of 25-hydroxyvitamin D3 1alpha-hydroxylase gene product in pseudovitamin D deficiency rickets, including that with mild clinical manifestation | Q73194246 | ||
| Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators | Q74485020 | ||
| The autonomous transactivation domain in helix H3 of the vitamin D receptor is required for transactivation and coactivator interaction | Q77726539 | ||
| The chromatin-remodeling complex WINAC targets a nuclear receptor to promoters and is impaired in Williams syndrome | Q28183858 | ||
| Regulation of CLOCK and MOP4 by nuclear hormone receptors in the vasculature: a humoral mechanism to reset a peripheral clock | Q28204879 | ||
| Combinatorial control of gene expression by nuclear receptors and coregulators | Q28209095 | ||
| Nuclear receptor function requires a TFTC-type histone acetyl transferase complex | Q28212676 | ||
| 25-Hydroxyvitamin D3 1alpha-hydroxylase and vitamin D synthesis | Q28248764 | ||
| Steroid receptor coactivator-1 is a histone acetyltransferase | Q28248899 | ||
| Phosphorylated CREB binds specifically to the nuclear protein CBP | Q28265019 | ||
| TFE3: a helix-loop-helix protein that activates transcription through the immunoglobulin enhancer muE3 motif | Q28284930 | ||
| A transcriptional co-repressor that interacts with nuclear hormone receptors | Q28289864 | ||
| Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo | Q28298865 | ||
| Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning | Q28508915 | ||
| A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression | Q28578229 | ||
| Cloning, gene structure and dietary regulation of the type-IIc Na/Pi cotransporter in the mouse kidney | Q28586984 | ||
| Regulation of CLOCK and MOP4 by Nuclear Hormone Receptors in the Vasculature | Q29544309 | ||
| The human estrogen receptor has two independent nonacidic transcriptional activation functions | Q29617089 | ||
| Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A | Q29617379 | ||
| Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase | Q29617567 | ||
| Steroid hormone receptors: many actors in search of a plot | Q29618397 | ||
| A decade of molecular biology of retinoic acid receptors | Q29619944 | ||
| A transcriptional switch mediated by cofactor methylation | Q34101080 | ||
| Nuclear receptors: a rendezvous for chromatin remodeling factors | Q35197820 | ||
| Parathyroid hormone activation of the 25-hydroxyvitamin D3-1alpha-hydroxylase gene promoter | Q35859594 | ||
| Targeted ablation of the 25-hydroxyvitamin D 1alpha -hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction | Q36312727 | ||
| Sequences in the human parathyroid hormone gene that bind the 1,25-dihydroxyvitamin D3 receptor and mediate transcriptional repression in response to 1,25-dihydroxyvitamin D3 | Q37178523 | ||
| The MyoD DNA binding domain contains a recognition code for muscle-specific gene activation | Q38341599 | ||
| Intron retention generates a novel isoform of the murine vitamin D receptor that acts in a dominant negative way on the vitamin D signaling pathway | Q38356179 | ||
| Selective interaction of vitamin D receptor with transcriptional coactivators by a vitamin D analog | Q39610821 | ||
| Estrogen receptor binding to DNA is not required for its activity through the nonclassical AP1 pathway | Q40817246 | ||
| Positive and negative regulations of the renal 25-hydroxyvitamin D3 1alpha-hydroxylase gene by parathyroid hormone, calcitonin, and 1alpha,25(OH)2D3 in intact animals | Q40958285 | ||
| The promoter of the human 25-hydroxyvitamin D3 1 alpha-hydroxylase gene confers positive and negative responsiveness to PTH, calcitonin, and 1 alpha,25(OH)2D3. | Q41016117 | ||
| The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. | Q41731155 | ||
| Mutations in the 1,25-dihydroxyvitamin D3 receptor identifying C-terminal amino acids required for transcriptional activation that are functionally dissociated from hormone binding, heterodimeric DNA binding, and interaction with basal transcription | Q42439013 | ||
| The Pan basic helix-loop-helix proteins are required for insulin gene expression | Q44960698 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1598-1608 | |
| P577 | publication date | 2004-04-01 | |
| P1433 | published in | The EMBO Journal | Q1278554 |
| P1476 | title | Transrepression by a liganded nuclear receptor via a bHLH activator through co-regulator switching | |
| P478 | volume | 23 |
| Q45147852 | 1 alpha,25-Dihydroxyvitamin D(3) is a preventive factor in the metastasis of lung cancer |
| Q35192119 | 1,25-dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A. |
| Q51578714 | 1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter. |
| Q51584487 | 1,25-dihydroxyvitamin D3 transcriptionally represses p45Skp2 expression via the Sp1 sites in human prostate cancer cells. |
| Q40210128 | 1Alpha,25(OH)2D3-induced transrepression by vitamin D receptor through E-box-type elements in the human parathyroid hormone gene promoter |
| Q56745447 | 1alpha,25(OH)2D3-induced DNA methylation suppresses the human CYP27B1 gene |
| Q40016935 | 1alpha,25-Dihydroxyvitamin D3 down-regulates expression of prostate specific membrane antigen in prostate cancer cells. |
| Q37226472 | 25-Hydroxyvitamin D3 is a natural chemopreventive agent against carcinogen induced precancerous lesions in mouse mammary gland organ culture |
| Q38930069 | A cis-acting element in the promoter of human ether à go-go 1 potassium channel gene mediates repression by calcitriol in human cervical cancer cells. |
| Q33832689 | A downstream intergenic cluster of regulatory enhancers contributes to the induction of CYP24A1 expression by 1alpha,25-dihydroxyvitamin D3. |
| Q34429704 | Action of vitamin D and the receptor, VDRa, in calcium handling in zebrafish (Danio rerio). |
| Q33606058 | Adenovirus-delivered microRNA targeting the vitamin D receptor reduces intracellular Ca²⁺ concentrations by regulating the expression of Ca²⁺-transport proteins in renal epithelial cells |
| Q39974503 | An emerging role for class I bHLH E2-2 proteins in EMT regulation and tumor progression |
| Q55233852 | Androgen receptor functions in male and female reproduction. |
| Q37578871 | Antiproliferative Effects of 1α-OH-vitD3 in Malignant Melanoma: Potential Therapeutic implications. |
| Q51576974 | Bone CYP27B1 gene expression is increased with high dietary calcium and in mineralising osteoblasts. |
| Q43248702 | CDP/cut is an osteoblastic coactivator of the vitamin D receptor (VDR). |
| Q43144652 | Calcitonin, a regulator of the 25-hydroxyvitamin D3 1alpha-hydroxylase gene |
| Q34326600 | Characterization of the autocrine/paracrine function of vitamin D in human gingival fibroblasts and periodontal ligament cells |
| Q40318820 | Complex role of the vitamin D receptor and its ligand in adipogenesis in 3T3-L1 cells |
| Q35008010 | DNA demethylation in hormone-induced transcriptional derepression |
| Q42458697 | Deletion of the vitamin D receptor specifically in the parathyroid demonstrates a limited role for the receptor in parathyroid physiology |
| Q40099511 | Detecting reliable gene interactions by a hierarchy of Bayesian network classifiers |
| Q35986087 | Dietary vitamin D₃ and 1,25-dihydroxyvitamin D₃ (calcitriol) exhibit equivalent anticancer activity in mouse xenograft models of breast and prostate cancer |
| Q82948550 | Direct suppression of Pth gene expression by the vitamin D prohormones doxercalciferol and calcidiol requires the vitamin D receptor |
| Q38548086 | Epigenetic Regulation of Cytochrome P450 Enzymes and Clinical Implication |
| Q36561789 | Equivalent anticancer activities of dietary vitamin D and calcitriol in an animal model of breast cancer: importance of mammary CYP27B1 for treatment and prevention |
| Q40059362 | Extracellular calcium-sensing receptor activation induces vitamin D receptor levels in proximal kidney HK-2G cells by a mechanism that requires phosphorylation of p38alpha MAPK. |
| Q38163235 | Fundamentals of vitamin D hormone-regulated gene expression |
| Q38202921 | Genomic binding sites and biological effects of the vitamin D--VDR complex in multiple sclerosis [corrected]. |
| Q33888569 | Genomic determinants of gene regulation by 1,25-dihydroxyvitamin D3 during osteoblast-lineage cell differentiation |
| Q37741229 | Genomics of long-range regulatory elements |
| Q36249040 | HNF4α antagonists discovered by a high-throughput screen for modulators of the human insulin promoter |
| Q37961800 | Hormonal gene regulation through DNA methylation and demethylation |
| Q47109494 | IGFBP-3 Interacts with the Vitamin D Receptor in Insulin Signaling Associated with Obesity in Visceral Adipose Tissue |
| Q35128849 | Inhibition of Methicillin-resistant Staphylococcus aureus-induced cytokines mRNA production in human bone marrow derived mesenchymal stem cells by 1,25-dihydroxyvitamin D3 |
| Q42808701 | Interference of E2-2-mediated effect in endothelial cells by FAM96B through its limited expression of E2-2. |
| Q40142565 | Involvement of NF-kappaB subunit p65 and retinoic acid receptors, RARalpha and RXRalpha, in transcriptional regulation of the human GnRH II gene |
| Q24537715 | Ligand-induced transrepression by VDR through association of WSTF with acetylated histones |
| Q79971397 | Ligand-induced transrepressive function of VDR requires a chromatin remodeling complex, WINAC |
| Q38875500 | MDM2 binds and inhibits vitamin D receptor |
| Q36848096 | Mechanisms of transcriptional repression by 1,25(OH)2 vitamin D. |
| Q35809076 | Mechanistic Effects of Calcitriol in Cancer Biology |
| Q40178947 | Metabolism of vitamin D in the human choriocarcinoma cell line JEG-3. |
| Q40152168 | Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1 alpha,25-dihydroxyvitamin D3. |
| Q46394734 | Modulation of CYP27B1 and CYP24 mRNA expression in bone is independent of circulating 1,25(OH)2D3 levels. |
| Q24302430 | Modulation of the vitamin D3 response by cancer-associated mutant p53 |
| Q37090974 | Molecular actions of 1,25-dihydroxyvitamin D3 on genes involved in calcium homeostasis |
| Q38126273 | Non-classical mechanisms of transcriptional regulation by the vitamin D receptor: insights into calcium homeostasis, immune system regulation and cancer chemoprevention |
| Q35620895 | Nuclear hormone 1α,25-dihydroxyvitamin D3 elicits a genome-wide shift in the locations of VDR chromatin occupancy |
| Q37726333 | Nuclear receptor repression: regulatory mechanisms and physiological implications. |
| Q26849574 | Nuclear receptors and epigenetic regulation: opportunities for nutritional targeting and disease prevention |
| Q26853017 | Nuclear receptors in bone physiology and diseases |
| Q37846708 | Omics underpins novel clues on VDR chemoprevention target in breast cancer |
| Q84077847 | PIAS4 represses vitamin D receptor-mediated signaling and acts as an E3-SUMO ligase towards vitamin D receptor |
| Q39670347 | Primary effect of 1α,25(OH)₂D₃ on IL-10 expression in monocytes is short-term down-regulation |
| Q59434651 | Regulation of Vitamin D hydroxylases gene expression by 1,25-dihydroxyvitamin D3 and cyclic AMP in cultured human syncytiotrophoblasts |
| Q37959635 | Regulation of intracrine production of 1,25-dihydroxyvitamin D and its role in innate immune defense against infection |
| Q37922621 | Regulation of target gene expression by the vitamin D receptor - an update on mechanisms |
| Q39838526 | Regulation of the 5'-flanking region of the human CYP27B1 gene in osteoblast cells. |
| Q38356094 | Regulation of the vitamin D receptor gene by environment, genetics and epigenetics |
| Q46745936 | Regulation of vitamin D metabolism |
| Q81362640 | Response of the 5'-flanking region of the human 25-hydroxyvitamin D 1alpha-hydroxylase gene to physiological stimuli using a transgenic mouse model |
| Q24302292 | Selective use of multiple vitamin D response elements underlies the 1 alpha,25-dihydroxyvitamin D3-mediated negative regulation of the human CYP27B1 gene |
| Q29616508 | Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response |
| Q40152082 | Splice variants of the CYP27b1 gene and the regulation of 1,25-dihydroxyvitamin D3 production |
| Q55551474 | The Pituitary Function of Androgen Receptor Constitutes a Glucocorticoid Production Circuit. |
| Q39871514 | The class I bHLH factors E2-2A and E2-2B regulate EMT. |
| Q50609805 | The claudin-16 channel gene is transcriptionally inhibited by 1,25-dihydroxyvitamin D. |
| Q42471868 | The down-regulation of the human MYC gene by the nuclear hormone 1alpha,25-dihydroxyvitamin D3 is associated with cycling of corepressors and histone deacetylases. |
| Q37908840 | The growing role of gene methylation on endocrine function |
| Q40549870 | The highly conserved region of the co-repressor Sin3A functionally interacts with the co-repressor Alien |
| Q35948133 | The pituitary function of androgen receptor constitutes a glucocorticoid production circuit |
| Q36596696 | The vitamin D receptor as a therapeutic target |
| Q37138638 | The vitamin D receptor in cancer |
| Q40345202 | The vitamin D receptor represses transcription of the pituitary transcription factor Pit-1 gene without involvement of the retinoid X receptor |
| Q37838638 | The vitamin D3 1alpha-hydroxylase gene and its regulation by active vitamin D3. |
| Q42519131 | Thyroid hormones decrease plasma 1α,25-dihydroxyvitamin D levels through transcriptional repression of the renal 25-hydroxyvitamin D3 1α-hydroxylase gene (CYP27B1). |
| Q22065387 | Transcriptional Regulatory Elements in the Human Genome |
| Q39142762 | Transrepression of the estrogen receptor promoter by calcitriol in human breast cancer cells via two negative vitamin D response elements |
| Q51536162 | Vitamin D analog EB1089 inhibits aromatase expression by dissociation of comodulator WSTF from the CYP19A1 promoter-a new regulatory pathway for aromatase. |
| Q27027710 | Vitamin D and colon cancer |
| Q36960938 | Vitamin D and colorectal cancer: molecular, epidemiological and clinical evidence. |
| Q36973933 | Vitamin D and human health: lessons from vitamin D receptor null mice. |
| Q38221116 | Vitamin D and its receptor during late development |
| Q33569349 | Vitamin D and the epigenome. |
| Q37783311 | Vitamin D in Chronic Kidney Disease: New Potential for Intervention |
| Q37887993 | Vitamin D metabolism and activity in the parathyroid gland |
| Q37887981 | Vitamin D metabolism within bone cells: effects on bone structure and strength |
| Q37000530 | Vitamin D receptor inhibits nuclear factor κB activation by interacting with IκB kinase β protein |
| Q36344273 | Vitamin D receptor signaling mechanisms: integrated actions of a well-defined transcription factor |
| Q39043864 | Vitamin D represses dentin matrix protein 1 in cementoblasts and osteocytes. |
| Q36061123 | Vitamin D resistance and colon cancer prevention |
| Q36919979 | Vitamin D signalling pathways in cancer: potential for anticancer therapeutics |
| Q39027226 | Vitamin D-dependent recruitment of corepressors to vitamin D/retinoid X receptor heterodimers |
| Q47803355 | Vitamin D-mediated regulation of CYP21A2 transcription - a novel mechanism for vitamin D action |
| Q83963403 | Vitamin D: metabolism |
| Q33888727 | Vitamin D: metabolism |
| Q37843469 | WSTF does it all: a multifunctional protein in transcription, repair, and replication |
| Q34159510 | Williams syndrome is an epigenome-regulator disease |
| Q79420561 | [Vitamin D: metabolism, regulation and associated diseases] |
Search more.